Skip to Main Content
Contribute Try STAT+ Today

WASHINGTON — Congress and the new Biden administration are taking another swing at lowering prescription drug prices.

This time, though, they might have the power to get something done. Unlike in 2019, when Congress failed to pass any meaningful drug pricing legislation and the Trump administration struggled to advance its own proposals, Democrats now enjoy full control of the federal government. Between the new Biden administration and razor-thin majorities in the Senate and House, the current environment could spell trouble for pharmaceutical companies.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Excellent summary; thank you. It illustrates just how little Congress as a whole does regarding drug pricing relief.

    If the average elderly (and not so elderly) consumer really understood just how much power is wielded by both Big Pharma AND pharmacy benefit managers there’d be seniors rioting in the streets.

    It’s not capitalism but, rather, legalized extortion protected by lobbying monies donated to Congresspeople. All those initiatives listed here – amounting to nothing, while many seniors have to choose between their medications and other basic necessities.

  • Thanks for the great summary of myriad of draft bills. I look forward your updates with info on the names of co-sponsors and the status of bills.

  • It really amazes me that our legislatures do not see or is it that they don’t
    want to really see where the problem of drug pricing is. Nothing regarding
    drug pricing will ever change until there are strict laws to govern the PBM’s.
    This is where the problem lies and will always be until the PBM’s are stopped
    from fleecing every American in this country. Why on earth would President
    Trump ” pull the plug” as he said on Drug Rebates? Do the PBM’s contribute
    that much money to both political parties so that every official in Washington
    looks the other way. PBM’s don’t want change in the system . It seems to me that’s exactly what they got. Why would they want change when they’re showing 60 BILLION dollars in profit every quarter !!!!

Comments are closed.